ATS 2018 International Conference - Mobile

John Ayrton

PhD

Verona Pharma

Session(s)

Low Oral Bioavailability of RPL554, a First-in-Class Dual PDE3/4 Inhibitor, Demonstrates t...
Monday, May 21 11:15 AM - 1:00 PM